CrossRef 22. Dasugupta MK, Shishida H, Salama S, Singh R, Larabie M, Micetich RG: The effect of macrolide and quinolone antibiotics in methicillin-resistant Staphylococcus aureus biofilm growth. Ad Perit Dial 1997, 13:214–217. 23. Tre-Hardy M, Nagant C, El MN, Vanderbist F, Traore H, Vaneechoutte M, Dehaye JP: Efficacy of the combination of tobramycin and a macrolide in an
in vitro Pseudomonas aeruginosa mature biofilm model. Antimicrob Agents PF299 manufacturer Chemother 2010, 54:4409–4415.PubMedCrossRef 24. Tre-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ: In vitro activity of antibiotic combinations against Pseudomonas aeruginosa Biofilm and planktonic cultures. Int J Antimicrob Agents 2008, 31:329–336.PubMedCrossRef 25. Cirioni O, Ghiselli R, Silvestri C, GSK3326595 clinical trial Minardi D, Gabrielli E, Orlando F, Rimini M, Brescini L, Muzzonigro G, Guerrieri M, Giacometti A: Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection. J Antimicrob Chemother 2011, 66:1318–1323.PubMedCrossRef 26. Bala A, Kumar R, Harjai K: Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections. J Med Microbiol 2011, 60:300–306.PubMedCrossRef
27. Gillis RJ, Iglewski BH: Azithromycin retards Pseudomonas aeruginosa Biofilm formation. J Clin Microbiol 2004, 42:5842–5845.PubMedCrossRef selleck compound 28. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K, Van DC: Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa . Antimicrob Agents Chemother 2001, 45:1930–1933.PubMedCrossRef 29. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M: Long term azithromycin in children with cystic fibrosis: a randomised,
placebo-controlled crossover trial. Lancet 2002, 360:978–984.PubMedCrossRef 30. Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J: Effect of long term Cell press treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002, 57:212–216.PubMedCrossRef 31. Saiman L, Chen Y, Gabriel PS, Knirsch C: Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia , and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 2002, 46:1105–1107.PubMedCrossRef 32. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH: Manual of clinical microbiology. 8th edition. Washington: ASM Press; 2003. 33. Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically M07-A8. 8th edition. Wayne: CLSI; 2009. 34. Clinical and Laboratory Standards Institute: Performance Standards for antimicrobial susceptibility testing. M100-S20. Wayne: CLSI; 2010. 35. Ichimiya T, Yamasaki T, Nasu M: In vitro effects of antimicrobial agents on Pseudomonas aeruginosa Biofilm formation. J Antimicrob Chemother 1994, 34:331–341.PubMedCrossRef 36.